Neuronetics, Inc.
STIM
$1.94
$0.2414.12%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 41.78M | 37.30M | 38.11M | 31.98M | 22.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 41.78M | 37.30M | 38.11M | 31.98M | 22.49M |
| Cost of Revenue | 19.67M | 20.19M | 20.35M | 16.24M | 7.00M |
| Gross Profit | 22.10M | 17.11M | 17.76M | 15.74M | 15.49M |
| SG&A Expenses | 25.08M | 22.93M | 24.02M | 25.14M | 20.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.42M | 44.62M | 46.17M | 42.99M | 33.37M |
| Operating Income | -4.64M | -7.32M | -8.06M | -11.01M | -10.87M |
| Income Before Tax | -7.21M | -9.40M | -9.84M | -12.69M | -12.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.21M | -9.40M | -9.84M | -12.69M | -12.68M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 48.00K | 356.00K | -281.00K | 14.00K | 19.00K |
| Net Income | -7.16M | -9.05M | -10.12M | -12.68M | -12.66M |
| EBIT | -4.64M | -7.32M | -8.06M | -11.01M | -10.87M |
| EBITDA | -3.94M | -6.44M | -7.16M | -10.10M | -10.52M |
| EPS Basic | -0.10 | -0.13 | -0.15 | -0.21 | -0.35 |
| Normalized Basic EPS | -0.06 | -0.08 | -0.10 | -0.13 | -0.21 |
| EPS Diluted | -0.10 | -0.13 | -0.15 | -0.21 | -0.35 |
| Normalized Diluted EPS | -0.06 | -0.08 | -0.10 | -0.13 | -0.21 |
| Average Basic Shares Outstanding | 68.76M | 67.31M | 66.18M | 61.47M | 36.67M |
| Average Diluted Shares Outstanding | 68.76M | 67.31M | 66.18M | 61.47M | 36.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |